Oxford Immune Algorithmics
PrivateLast Round
Grant
Nov 6, 2022
Est. Valuation
$67.78M
Total Funding Raised
$14.07M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Oxford Immune Algorithmics operates in Healthcare & Life Sciences and is based in Reading. Its latest recorded funding round was a Grant round in November 2022.
Oxford Immune Algorithmics is a health technology company that develops Algocyte, a platform for predictive and personalized healthcare through remote immune system monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Immune Algorithmics Comparables
Compare Oxford Immune Algorithmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Soulbrain Holdings Co. Ltd | 77% | |
| Commure | 71% | |
| Sight Diagnostics | 70% |
For institutional investors. Book with your work email.
Oxford Immune Algorithmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 6, 2022 | ||||
| Series A | Mar 6, 2021 | ||||
| Seed | Dec 17, 2020 | ||||
| Seed | Apr 28, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oxford Immune Algorithmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EPSRC | Grant |
| MedTech AI Inc. | Series A |
| SFC Capital | Series A, Seed |
| Kin Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 2712% to 1.4K.
- Jul 26, 2026
Monthly visitors grew 108% MoM.
For institutional investors. Book with your work email.
Oxford Immune Algorithmics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oxford Immune Algorithmics's valuation, stock price, and market status.
Is Oxford Immune Algorithmics a public or private company?
Oxford Immune Algorithmics is a private company.
What is the current stock price of Oxford Immune Algorithmics?
Oxford Immune Algorithmics is a private company, so its shares have no public market price. Caplight tracks Oxford Immune Algorithmics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oxford Immune Algorithmics worth (valuation)?
Oxford Immune Algorithmics's valuation is estimated at $67.8M based on funding round data.
Can I buy Oxford Immune Algorithmics stock?
Oxford Immune Algorithmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oxford Immune Algorithmics's last funding round?
Oxford Immune Algorithmics's most recent funding round was Grant on November 6, 2022.
Who are the main investors in Oxford Immune Algorithmics?
Key investors in Oxford Immune Algorithmics include MedTech AI Inc., SFC Capital, Kin Capital.
Will Oxford Immune Algorithmics IPO soon?
No public IPO plans have been announced for Oxford Immune Algorithmics.
How can I track Oxford Immune Algorithmics secondary market activity?
Caplight tracks bids, offers, and trades in Oxford Immune Algorithmics's shares on secondary markets.